Towards therapy of Gaucher's disease by gene transfer into hematopoietic cells.
Correll
P H
PH
National Institute of Neurological Disease and Stroke, NIH, Bethesda, MD 20892.
Karlsson
S
S
D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34; D002460:Cell Line; D005776:Gaucher Disease / Q000628:therapy*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D005962:Glucosylceramidase / Q000235:genetics*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006412:Hematopoietic Stem Cells; D006801:Humans; D007937:Leukapheresis; D051379:Mice
D015703:Antigens, CD; D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor; D005962:Glucosylceramidase